Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation
Clinical trial NCT00201799 · COMPLETED
Trial details
- NCT number
- NCT00201799
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2006-08-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.